Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  ibritumomab tiuxetan
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Ibritumomab Tiuxetan before Donor Peripheral Blood Stem Cell Transplant in Treating Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 to 75
Trial IDs: UCDCC#233, NCI-2012-02753, NCT01811368
Start Over